Retractable Technologies, Inc. (NYSE:RVP) CEO Thomas J. Shaw Purchases 49,541 Shares

Retractable Technologies, Inc. (NYSE:RVP) CEO Thomas J. Shaw purchased 49,541 shares of the company’s stock in a transaction dated Thursday, August 7th. The stock was purchased at an average price of $0.75 per share, for a total transaction of $37,155.75. Following the transaction, the chief executive officer directly owned 15,578,754 shares in the company, valued at approximately $11,684,065.50. This trade represents a 0.32% increase in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website.

Retractable Technologies Stock Up 5.3%

Retractable Technologies stock opened at $0.82 on Tuesday. The company has a quick ratio of 5.92, a current ratio of 8.57 and a debt-to-equity ratio of 0.01. Retractable Technologies, Inc. has a 12-month low of $0.56 and a 12-month high of $1.10. The firm’s fifty day moving average is $0.68 and its 200 day moving average is $0.72. The company has a market capitalization of $24.43 million, a PE ratio of -1.51 and a beta of 1.15.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in Retractable Technologies stock. Renaissance Technologies LLC lifted its stake in shares of Retractable Technologies, Inc. (NYSE:RVP) by 9.4% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 361,253 shares of the company’s stock after acquiring an additional 31,140 shares during the period. Renaissance Technologies LLC owned 1.21% of Retractable Technologies worth $249,000 at the end of the most recent reporting period. 7.58% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Separately, Wall Street Zen started coverage on shares of Retractable Technologies in a research report on Thursday, May 22nd. They issued a “hold” rating on the stock.

About Retractable Technologies

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.